| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2724991 | The American Journal of Medicine | 2008 | 7 Pages |
Abstract
The incidence of carbohydrate intolerance and overt diabetes is increased in patients with schizophrenia treated with the newer atypical antipsychotic agents. The precise mechanism for these abnormalities remains obscure. This review examines the potential interaction between atypical antipsychotic medications and several hormones known to influence appetite regulation and carbohydrate metabolism.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Alan N. Elias, Heather Hofflich,